171 related articles for article (PubMed ID: 22976296)
1. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes.
Faherty N; Curran SP; O'Donovan H; Martin F; Godson C; Brazil DP; Crean JK
J Cell Sci; 2012 Dec; 125(Pt 23):5621-9. PubMed ID: 22976296
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
O'Donovan HC; Hickey F; Brazil DP; Kavanagh DH; Oliver N; Martin F; Godson C; Crean J
Biochem J; 2012 Jan; 441(1):499-510. PubMed ID: 21871016
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma.
Lo SS; Hung PS; Chen JH; Tu HF; Fang WL; Chen CY; Chen WT; Gong NR; Wu CW
Oncogene; 2012 Jan; 31(2):226-37. PubMed ID: 21666718
[TBL] [Abstract][Full Text] [Related]
6. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
7. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
8. A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor II.
Li L; Li G; Yu C; Shen Z; Xu C; Feng Z; Zhang X; Li Y
Liver Int; 2015 Apr; 35(4):1124-32. PubMed ID: 24351048
[TBL] [Abstract][Full Text] [Related]
9. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
McLean S; Di Guglielmo GM
Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
[TBL] [Abstract][Full Text] [Related]
10. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
11. Tgfbeta receptor expression in lens: implications for differentiation and cataractogenesis.
de Iongh RU; Gordon-Thomson C; Chamberlain CG; Hales AM; McAvoy JW
Exp Eye Res; 2001 Jun; 72(6):649-59. PubMed ID: 11384153
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells.
Castro NE; Kato M; Park JT; Natarajan R
J Biol Chem; 2014 Oct; 289(42):29001-13. PubMed ID: 25204661
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-15a/b accelerates fibrotic remodelling in the Type 2 diabetic human and mouse heart.
Rawal S; Munasinghe PE; Nagesh PT; Lew JKS; Jones GT; Williams MJA; Davis P; Bunton D; Galvin IF; Manning P; Lamberts RR; Katare R
Clin Sci (Lond); 2017 May; 131(9):847-863. PubMed ID: 28289072
[No Abstract] [Full Text] [Related]
14. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
Kato M; Zhang J; Wang M; Lanting L; Yuan H; Rossi JJ; Natarajan R
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3432-7. PubMed ID: 17360662
[TBL] [Abstract][Full Text] [Related]
16. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of the transforming growth factor beta type II receptor disrupts mesoderm organisation during mouse gastrulation.
Zwijsen A; Goumans MJ; Lawson KA; Van Rooijen MA; Mummery CL
Dev Dyn; 1999 Feb; 214(2):141-51. PubMed ID: 10030593
[TBL] [Abstract][Full Text] [Related]
19. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.
Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P
Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224
[TBL] [Abstract][Full Text] [Related]
20. TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation.
Faherty N; O'Donovan H; Kavanagh D; Madden S; McKay GJ; Maxwell AP; Martin F; Godson C; Crean J
BMC Genomics; 2013 Aug; 14():525. PubMed ID: 23902294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
